469 related articles for article (PubMed ID: 27553089)
21. Methylation of DACT2 promotes breast cancer development by activating Wnt signaling.
Li J; Zhang M; He T; Li H; Cao T; Zheng L; Guo M
Sci Rep; 2017 Jun; 7(1):3325. PubMed ID: 28607412
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic inactivation of galanin and GALR1/2 is associated with early recurrence in head and neck cancer.
Misawa K; Misawa Y; Kanazawa T; Mochizuki D; Imai A; Endo S; Carey TE; Mineta H
Clin Exp Metastasis; 2016 Feb; 33(2):187-95. PubMed ID: 26572146
[TBL] [Abstract][Full Text] [Related]
23. Expression and epigenetic modulation of sonic hedgehog-GLI1 pathway genes in neuroblastoma cell lines and tumors.
Shahi MH; Schiapparelli P; Afzal M; Sinha S; Rey JA; Castresana JS
Tumour Biol; 2011 Feb; 32(1):113-27. PubMed ID: 20830616
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the methylation profile of exfoliated cell samples from patients with head and neck squamous cell carcinoma.
Longo AL; Rettori MM; de Carvalho AC; Kowalski LP; Carvalho AL; Vettore AL
Head Neck; 2014 May; 36(5):631-7. PubMed ID: 23595968
[TBL] [Abstract][Full Text] [Related]
25. The neuropeptide genes
Misawa K; Mima M; Imai A; Mochizuki D; Misawa Y; Endo S; Ishikawa R; Kanazawa T; Mineta H
Clin Epigenetics; 2018; 10():52. PubMed ID: 29682090
[TBL] [Abstract][Full Text] [Related]
26. Characterization of gene methylation in human papillomavirus associated-head and neck squamous cell carcinoma.
Zhang HZ; Shan CG; Huang AP; Wang JM
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706614
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma.
Chaisaingmongkol J; Popanda O; Warta R; Dyckhoff G; Herpel E; Geiselhart L; Claus R; Lasitschka F; Campos B; Oakes CC; Bermejo JL; Herold-Mende C; Plass C; Schmezer P
Oncogene; 2012 Dec; 31(49):5108-16. PubMed ID: 22286769
[TBL] [Abstract][Full Text] [Related]
28. Protein expression and promoter methylation of the candidate biomarker TCF21 in head and neck squamous cell carcinoma.
Weiss D; Stockmann C; Schrödter K; Rudack C
Cell Oncol (Dordr); 2013 Jun; 36(3):213-24. PubMed ID: 23529585
[TBL] [Abstract][Full Text] [Related]
29. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
[TBL] [Abstract][Full Text] [Related]
30. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
[TBL] [Abstract][Full Text] [Related]
31. Prognostic potential of KLOTHO and SFRP1 promoter methylation in head and neck squamous cell carcinoma.
Alsofyani AA; Alsiary RA; Samkari A; Alhaj-Hussain BT; Khan JA; Al-Maghrabi J; Elaimi A; Al-Qahtani MH; Abuzenadah AM; Dallol A
J Appl Genet; 2017 Nov; 58(4):459-465. PubMed ID: 28812223
[TBL] [Abstract][Full Text] [Related]
32. Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype.
Sengupta S; Chakrabarti S; Roy A; Panda CK; Roychoudhury S
Cancer; 2007 Feb; 109(4):703-12. PubMed ID: 17219447
[TBL] [Abstract][Full Text] [Related]
33. Differential methylation status of tumor-associated genes in head and neck squamous carcinoma: incidence and potential implications.
Maruya S; Issa JP; Weber RS; Rosenthal DI; Haviland JC; Lotan R; El-Naggar AK
Clin Cancer Res; 2004 Jun; 10(11):3825-30. PubMed ID: 15173091
[TBL] [Abstract][Full Text] [Related]
34. Recurrent epigenetic silencing of the PTPRD tumor suppressor in laryngeal squamous cell carcinoma.
Szaumkessel M; Wojciechowska S; Janiszewska J; Zemke N; Byzia E; Kiwerska K; Kostrzewska-Poczekaj M; Ustaszewski A; Jarmuz-Szymczak M; Grenman R; Wierzbicka M; Bartochowska A; Szyfter K; Giefing M
Tumour Biol; 2017 Mar; 39(3):1010428317691427. PubMed ID: 28345455
[TBL] [Abstract][Full Text] [Related]
35. The study of p16 and p15 gene methylation in head and neck squamous cell carcinoma and their quantitative evaluation in plasma by real-time PCR.
Wong TS; Man MW; Lam AK; Wei WI; Kwong YL; Yuen AP
Eur J Cancer; 2003 Sep; 39(13):1881-7. PubMed ID: 12932666
[TBL] [Abstract][Full Text] [Related]
36. Frequent inactivation of SLIT2 and ROBO1 signaling in head and neck lesions: clinical and prognostic implications.
Maiti GP; Ghosh A; Mondal P; Ghosh S; Chakraborty J; Roy A; Roychowdhury S; Panda CK
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Feb; 119(2):202-12. PubMed ID: 25465073
[TBL] [Abstract][Full Text] [Related]
37. DACT2 silencing by promoter CpG methylation disrupts its regulation of epithelial-to-mesenchymal transition and cytoskeleton reorganization in breast cancer cells.
Xiang T; Fan Y; Li C; Li L; Ying Y; Mu J; Peng W; Feng Y; Oberst M; Kelly K; Ren G; Tao Q
Oncotarget; 2016 Oct; 7(43):70924-70935. PubMed ID: 27708215
[TBL] [Abstract][Full Text] [Related]
38. Identification of FOXM1-induced epigenetic markers for head and neck squamous cell carcinomas.
Hwang S; Mahadevan S; Qadir F; Hutchison IL; Costea DE; Neppelberg E; Liavaag PG; Waseem A; Teh MT
Cancer; 2013 Dec; 119(24):4249-58. PubMed ID: 24114764
[TBL] [Abstract][Full Text] [Related]
39. Recurrent transcriptional loss of the PCDH17 tumor suppressor in laryngeal squamous cell carcinoma is partially mediated by aberrant promoter DNA methylation.
Byzia E; Soloch N; Bodnar M; Szaumkessel M; Kiwerska K; Kostrzewska-Poczekaj M; Jarmuz-Szymczak M; Szylberg L; Wierzbicka M; Bartochowska A; Kalinowicz E; Grenman R; Szyfter K; Marszalek A; Giefing M
Mol Carcinog; 2018 Jul; 57(7):878-885. PubMed ID: 29566279
[TBL] [Abstract][Full Text] [Related]
40. Gene promoter methylation signature predicts survival of head and neck squamous cell carcinoma patients.
Kostareli E; Hielscher T; Zucknick M; Baboci L; Wichmann G; Holzinger D; Mücke O; Pawlita M; Del Mistro A; Boscolo-Rizzo P; Da Mosto MC; Tirelli G; Plinkert P; Dietz A; Plass C; Weichenhan D; Hess J
Epigenetics; 2016; 11(1):61-73. PubMed ID: 26786582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]